DePree B, Houghton K, DiBenedetti DB, Shiozawa A, King DD, Kim J, Mancuso S. Practice patterns and perspectives regarding treatment for symptoms of menopause: qualitative interviews with US health care providers. Menopause. 2023 Feb;30(2):128-35. doi: 10.1097/GME.0000000000002096
Hagino H, Yoshinaga Y, Hamaya E, Lin TC, Ajmera M, Meyers J. A real-world study of treatment patterns among patients with osteoporotic fracture: analysis of a Japanese hospital database. Arch Osteoporosis. 2023 Jan 23;18(1):23. doi: 10.1007/s11657-022-01201-x
DePree B, Houghton K, Shiozawa A, Esterberg E, King D, Kim J, Mancuso S. Treatment and resource utilization for menopausal symptoms in the United States: a retrospective review of real-world evidence from US electronic health records. Menopause. 2023 Jan 1;30(1):70-9. doi: 10.1097/GME.0000000000002095
DePree B, Houghton K, Shiozawa A, Esterberg E, Kim J, Mancuso S. Real-world treatment for menopausal symptoms in the US by practitioner type. Poster presented at the American College of Obstetricians and Gynecologists (ACOG) 2022 Annual Meeting; May 6, 2022. San Diego, CA.
Anderson S, Mauskopf J, Talbird SE, White A, Meenakshi S. Antiseizure medications and oral contraceptives: impact of enzyme inducers on pregnancy outcomes and costs. Epilepsy Behav. 2021 Dec;125:108368. doi: 10.1016/j.yebeh.2021.108368
DePree B, Houghton K, Shiozawa A, Esterberg E, King D, Kim J, Mancuso S. Real-world treatment and resource utilization for menopausal symptoms in the United States. Presented at the 2021 North American Menopause Society (NAMS) Annual Meeting; September 23, 2021.
Doherty K, Barry M, Belisario JM, Morrison C, Car J, Doherty G. Personal information and public health: design tensions in sharing and monitoring wellbeing in pregnancy. Int J Hum Comput Stud. 2020 Mar;135:102373. doi: 10.1016/j.ijhcs.2019.102373
Filonenka A, Law A, Purser M, Mader G, Graham J. Economic burden of unintended pregnancy in the United States. Poster presented at the 2019 ISPOR 24th Annual International Meeting; May 20, 2019. New Orleans, LA.
Houghton K, Ainsworth C, Stull D, Haberland C, Filonenko A, Seitz C, Gerlinger C. Exploring variability in patient-reported pain and treatment efficacy in patients with endometriosis. Poster presented at the 2019 ISPOR 24th Annual International Meeting; May 20, 2019. New Orleans, LA.
Doherty K, Marcano-Belisario J, Cohn M, Mastellos N, Morrison C, Car J, Doherty G. Engagement with mental health screening on mobile devices: results from an antenatal feasibility study. Poster presented at the 2019 CHI Conference on Human Factors in Computing Systems; May 2019. Glasgow, Scotland. doi: 10.1145/3290605.3300416
Grand TS, Basarir H, Jackson LJ. The cost-effectiveness of oral contraceptives compared to ‘no hormonal treatment‘ for endometriosis-related pain: an economic evaluation. PLoS One. 2019 Jan 30;14(1):e0210089. doi: 10.1371/journal.pone.0210089
Doherty K, Barry M, Marcano-Belisario J, Arnaud B, Morrison C, Car J, Doherty G. A mobile app for the self-report of psychological well-being during pregnancy (BrightSelf): qualitative design study. JMIR Ment Health. 2018 Nov 27;5(4):e10007. doi: 10.2196/10007
Hillemeier MM, Domino ME, Wells R, Goyal RK, Kum HC, Cilenti D, Basu A. Does maternity care coordination influence perinatal health care utilization? Evidence from North Carolina. Health Serv Res. 2018 Aug;53(4):2368-83. doi: 10.1111/1475-6773.12742
Stebbins KL, Herring WL, Grant TJ, Mladsi DM, Witkowski C, Garg S. Cost savings associated with teleretinal imaging in primary care. Poster presented at the 2018 American Telemedicine Association (ATA) Annual Conference; April 30, 2018. Chicago, IL.
Anderson S, Halpern CT. Characterizing pregnancy scares and their association with perceived infertility. Poster presented at the 2018 Population Association of America Meeting; April 27, 2018. Denver, CO. doi: 10.1002/ajcp.12305
Marcano Belisario JS, Doherty K, O'Donoghue J, Ramchandani P, Majeed A, Doherty G, Morrison C, Car J. A bespoke mobile application for the longitudinal assessment of depression and mood during pregnancy: protocol of a feasibility study. BMJ Open. 2017 May 29;7(5):e014469. doi: 10.1136/bmjopen-2016-014469
Marcano-Belisario JS, Gupta AK, O'Donoghue J, Ramchandani P, Morrison C, Car J. Implementation of depression screening in antenatal clinics through tablet computers: results of a feasibility study. BMC Med Inform Decis Mak. 2017 May 10;17(1):59. doi: 10.1186/s12911-017-0459-8
Barry M, Doherty K, Marcano-Belisario J, Car J, Morrison C, Doherty G. mHealth for maternal mental health: everyday wisdom in ethical design. Poster presented at the 2017 CHI Conference on Human Factors in Computing Systems; May 2017. Denver, CO.
Halpern CT, Hassmiller Lich K, Anderson S. Demographic correlates of U.S. pregnancy scares from 2006-2013. Presented at the 2017 Population Association of America (PPA) Meeting; April 28, 2017. Chicago, IL.
Lairson DR, Parikh RC, Cormier JN, Wenyaw C, Du XL. Cost-effectiveness of chemotherapy for breast cancer and age effect in older women. Value Health. 2015 Dec;18(8):1070-8. doi: 10.1016/j.jval.2015.08.008
Boardman HM, Hartley L, Eisinga A, Main C, Roque i Figuls M, Bonfill Cosp X, Gabriel Sanchez R, Knight B. Hormone therapy for preventing cardiovascular disease in post-menopausal women. Cochrane Database Syst Rev. 2015 Mar 10;3:CD002229. doi: 10.1002/14651858.CD002229
Cilenti D, Kum HC, Wells R, Whitmire JT, Goyal RK, Hillemeier MM. Changes in North Carolina maternal health service use and outcomes among medicaid-enrolled pregnant women during state budget cuts. J Public Health Manag Pract. 2015 Mar;21(2):208-13. doi: 10.1097/PHH.0000000000000118
Hillemeier MM, Domino ME, Wells R, Goyal RK, Kum HC, Cilenti D, Timothy Whitmire J, Basu A. Effects of maternity care coordination on pregnancy outcomes: propensity-weighted analyses. Matern Child Health J. 2015 Jan;19(1):121-7. doi: 10.1007/s10995-014-1502-3
Goyal RK, Wheeler SB, Kohler RE, Lich KH, Lin CC, Reeder-Hayes K, Meyer AM, Mayer DK. Health care utilization from chemotherapy-related adverse events among low-income breast cancer patients: effect of enrollment in a medical home program. N C Med J. 2014 Jul;75(4):231-8.
Lairson DR, Parikh RC, Cormier JN, Du XL. Cost-utility analysis of platinum-based chemotherapy versus taxane and other regimens for ovarian cancer. Value Health. 2014 Feb;17(1):34-42.
Parikh RC, Lairson DR, Cormier JN, Du XL. Cost-utility analysis of various chemotherapy regimens among elderly ovarian cancer patients: a longitudinal cohort study. Poster presented at the 29th International Conference on Pharmacoepidemiology and Therapeutic Risk Management Conference; August 2013. Montreal, Canada. [abstract] Pharmacoepidemiol Drug Saf. 2013 Oct; 22(Suppl 1):172. doi: 10.1002/pds.3512
Du XL, Parikh RC, Lairson DR, Giordano SH, Cen P. Comparative effectiveness of platinum-based chemotherapy versus taxane and other regimens for ovarian cancer. Med Oncol. 2013 Mar;30(1):440. doi: 10.1007/s12032-012-0440-4
Parikh R, Taychakhoonavudh S, Ganduglia C, Franzini L. Geographic variation in cesarean section rates across hospital referral regions in Texas: a 2008-2010 analysis. Poster presented at the 13th Kelsey Research Foundation Health Services and Outcomes Research Annual Conference; December 2012. Houston, TX.
Karve S, Candrilli S, Kappelman MD, Tolleson-Rinehart S, Tennis P, Andrews E. Healthcare utilization and comorbidity burden among children and young adults in the United States with Systemic Lupus Erythematosus or Inflammatory Bowel Disease. J Pediatr. 2012 Oct 1;161(4):662-670.e. doi: 10.1016/j.jpeds.2012.03.045
Domino M, Wells R, Cilenti D, Kum H-C, Goyal RK, Whitmire T, Summers R. How sensitive are local health departments to funding cuts? An application to maternal care services. Poster presented at the American Society of Health Economists; October 2012. Minneapolis, MN.
Cilenti D, Wells R, Kum HC, Domino M, Goyal RK, Hillemeier M. How NC maternal and child health services and outcomes changed during a period of revenue cuts. Poster presented at the NC Public Health Association Conference; September 2012.
Boulanger L, Wu N, Chen SY, Nagar S, Fraser K, Bernauer MJ, Zhao Z, Zhao Y. Predictors of pain medication selection among patients diagnosed with fibromyalgia. Pain Pract. 2012 Apr;12(4):266-75.
Stull DE, Houghton KF, Filonenko A. Study heterogeneity in treatment response in women with idiopathic menorrhagia treated with levonorgestrel-releasing intrauterine system (LGN-IUS): application of innovative methods to identify differential response. Presented at the 2011 ISPOR 14th Annual European Congress; November 5, 2011. Madrid, Spain.
Taylor TN, Farkouh RA, Graham JB, Colligs A, Lindemann M, Lynen R, Candrilli SD. Potential reduction in neural tube defects associated with use of metafolin-fortified oral contraceptives in the United States. Am J Obstet Gynecol. 2011 Nov 1;205(5):460.e1-8.
Meyers JL, Meyers S. Inpatient costs of low birth weight and pre-term infant stays in the United States in 2008. Poster presented at the 2011 ISPOR 16th Annual International Meeting; May 31, 2011. [abstract] Value Health. 2011 May; 14(3):A107.
Talbird SE, Bell K, Graham JB, Deal L, Mauskopf J. Cost-effectiveness analysis for treatment of symptomatic uterine fibroids among premenopausal women seeking to retain uterus. Poster presented at the 2010 ISPOR 15th Annual International Meeting; May 26, 2010. [abstract] Value Health. 2010 May; 13(3):A183.
Bapat B, Davis KL, Bell K, Deal L, Talbird SE. Treatment patterns and economic burden of uterine fibroids in a United States managed care database. Poster presented at the 2010 ISPOR 15th Annual International Meeting; May 25, 2010. [abstract] Value Health. 2010 May; 13(3):A182.
Sikirica V, Bapat BS, Candrilli SD, Davis KL, Johns A. Economic burden of inpatient adhesiolysis in the female reproductive system in the US in 2005. Poster presented at the American College of Obstetricians and Gynecologists 57th Annual Clinical Meeting; May 2009.
Candrilli SD, Davis KL, Balkrishnan R. Inpatient length of stay and total costs of illnesses of pressing concern for Asian-American and Pacific Islander women in the United States. Poster presented at the 2008 ISPOR 11th Annual European Congress; November 2008. Athens, Greece. [abstract] Value Health. 2008 Nov; 11(6):A424. Previously presented at the 3rd Annual Asia-Pacific Conference of the International Society for Pharmacoeconomics and Outcomes Research.
Candrilli SD, Davis KL, Balkrishnan R. Inpatient length of stay and total costs of illnesses of pressing concern for Asian-American and Pacific Islander women in the United States. Poster presented at the 2008 ISPOR 3rd Annual Asia-Pacific Conference; September 2008. [abstract] Value Health. 2008 Nov; 11(6):A424.
Sunyecz J, Silberman C, Poston S, Earnshaw SR. Cost-effectiveness of ibandronate therapy for women with postmenopausal osteoporosis with respect to nonvertebral fracture efficacy. Poster presented at the 30th Annual Meeting of the American Society for Bone and Mineral Research; September 2008.
Heintz E, Brodtkorb T, Nelson N, Levin LA. The long-term cost-effectiveness of fetal monitoring during labour: a comparison of cardiotocography complemented with ST analysis versus cardiotocography alone. BJOG. 2008;115(13):1676-87.
Earnshaw SR, Graham CN, Ettinger B, Amonkar MM, Lynch NO, Middelhoven H. Cost-effectiveness of bisphosphonate therapies for women with postmenopausal osteoporosis: implications of improved persistence with less frequently administered oral bisphosphonates. Curr Med Res Opin. 2007 Oct 1;23(10):2517-29.
Lynch NO, Earnshaw SR, Graham CN, Patroe V, Boisdron J, Middelhoven H. Ibandronate IV injection is cost-effective in the treatment of UK women with postmenopausal osteoporosis who are intolerant to oral bisphosphonates. Poster presented at the European League Against Rheumatism (EULAR) 2007 Annual European Congress of Rheumatology; June 2007.
Lynch NO, Earnshaw SR, Graham CN, Middelhoven H. Cost-effectiveness of ibandronate injection IV in the treatment of UK women with postmenopausal osteoporosis who are intolerant to oral bisphosphonates. Poster presented at the Seventh European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ECCEO); March 2007.
Pignone M, Earnshaw S, Pletcher MJ, Tice JA. Aspirin for the primary prevention of cardiovascular disease in women: a cost-utility analysis. Arch Intern Med. 2007 Feb 12;167(3):290-5.
Earnshaw SR, Graham CN, Amonkar MM, Poston SA, Barr CE. Cost-effectiveness of ibandronate intravenous injection in the treatment of US women with postmenopausal osteoporosis. Poster presented at the 2006 American College of Rheumatology Scientific Meeting; November 2006.
Earnshaw SR, Beard SM, Lynch NO, Cooper A, Cowell W, Middelhoven H. A comparison of the cost-effectiveness of bisphosphonates using persistence data from a UK propsective rct. Poster presented at the 28th Annual Meeting of the American Society for Bone and Mineral Research; September 19, 2006.
Earnshaw SR, Beard SM, Lynch NO, Cowell W. Ibandronate in the treatment of postmenopausal osteoporosis: a cost-effectiveness analysis in the UK. Poster presented at the European League Against Rheumatism Annual European Congress of Rheumatology; June 24, 2006.
Moreland S, Talbird SE. Achieving the Millennium Development Goals: the contribution of fulfilling the unmet need for family planning. 2006.